Hemab Therapeutics names Keli Walbert to board, adds her to audit committee
Bitget2026/09/24 20:01- Hemab Therapeutics appointed Keli Walbert to its board, effective Sept. 24, 2026.
- Walbert will join the board’s Audit Committee, replacing Akshay Vaishnaw.
- Walbert most recently served as executive vice president of U.S. commercial at Horizon Therapeutics.
- Her background includes commercial leadership roles at AbbVie, the American Medical Association, Abbott, United Healthcare.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cathie Wood Takes ARK Venture Fund Onchain With Securitize
Litecoin Hits 8-Month High as ETF Holdings Set Record — Can Bulls Clear $75?
University of Michigan September Consumer Sentiment Index falls to a four-month low, inflation expectations for the next year rise to 4.6%
The final value of the US Michigan Consumer Sentiment Index for September dropped to 48.1, reaching a four-month low. Consumers expect inflation over the next year to be 4.6%, higher than last month's 4%. The expected annualized inflation rate for the next 5 to 10 years is 3.4%, the highest level since May. US gasoline and diesel prices have climbed, and mortgage rates have surpassed 7%. According to the survey leader, despite political differences, consumers unanimously believe the economic outlook has worsened.
US Stock Market Movement | Computing Power Bottleneck Gradually Emerges, Meta (META.US) Drops Over 3%
On Friday, Meta (META.US) opened lower and continued to fall, with a decline of over 3% as of press time, and a market capitalization of approximately $1.92 trillion.
Crypto prices
More
